ITGAX and amyotrophic lateral sclerosis: Our experimental observations seem to be in line with a previous report of an acute and transient increase in a population of CD11b myeloid cells expressing HLA-DR, CD11c and CX3CR1 in ALS individuals with a slower disease progression [7].